JNJ

227.25

-0.15%↓

UNH

370.37

+1.02%↑

TMO

465.89

-0.95%↓

ISRG

452.38

-3.02%↓

ABT

91.51

-2.44%↓

JNJ

227.25

-0.15%↓

UNH

370.37

+1.02%↑

TMO

465.89

-0.95%↓

ISRG

452.38

-3.02%↓

ABT

91.51

-2.44%↓

JNJ

227.25

-0.15%↓

UNH

370.37

+1.02%↑

TMO

465.89

-0.95%↓

ISRG

452.38

-3.02%↓

ABT

91.51

-2.44%↓

JNJ

227.25

-0.15%↓

UNH

370.37

+1.02%↑

TMO

465.89

-0.95%↓

ISRG

452.38

-3.02%↓

ABT

91.51

-2.44%↓

JNJ

227.25

-0.15%↓

UNH

370.37

+1.02%↑

TMO

465.89

-0.95%↓

ISRG

452.38

-3.02%↓

ABT

91.51

-2.44%↓

Search

Cytek Biosciences Inc

Cerrado

SectorSanidad

4.42 -3.49

Resumen

Variación precio

24h

Actual

Mínimo

4.35

Máximo

4.55

Métricas clave

By Trading Economics

Ingresos

-39M

-44M

Ventas

9.8M

62M

Margen de beneficios

-70.929

Empleados

702

EBITDA

4M

-263K

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+40.13% upside

Dividendos

By Dow Jones

Próximas Ganancias

7 may 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

12M

573M

Apertura anterior

7.91

Cierre anterior

4.42

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

177 / 348 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Weak Bullish Evidence

Cytek Biosciences Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

28 abr 2026, 23:33 UTC

Acciones populares

Stocks to Watch: Robinhood, Visa, Seagate Technology, NXP Semiconductors

28 abr 2026, 23:24 UTC

Ganancias

Visa 2Q Revenue Climbs as Consumers Keep Spending; Board Authorizes $20 Billion Buyback -- Update

28 abr 2026, 23:15 UTC

Noticias de Eventos Importantes

U.K. Economy to Suffer Large Loss of Output, Higher Inflation as Result of Middle East Conflict

28 abr 2026, 22:46 UTC

Ganancias

Booking Holdings Cuts Outlook as Middle East Conflict Weighs on Travel Demand -- Update

28 abr 2026, 22:37 UTC

Ganancias

Prudential PLC 1Q New Business Profit $686.0 Million, Up 10% on Year

28 abr 2026, 22:15 UTC

Ganancias
Noticias de Eventos Importantes

Mondelez Reports Developing Market Growth Offsetting U.S., Europe Weakness -- Update

28 abr 2026, 23:33 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Gold Edges Lower on Prospects of Dollar Strength -- Market Talk

28 abr 2026, 23:31 UTC

Ganancias

China Petroleum & Chemical 1Q Net Rose on Higher Crude Oil Prices >0386.HK

28 abr 2026, 23:31 UTC

Ganancias

China Petroleum & Chemical 1Q Capex Was CNY25.17B >0386.HK

28 abr 2026, 23:30 UTC

Ganancias

China Petroleum & Chemical 1Q Net CNY17.74B Vs. Net CNY13.98B >0386.HK

28 abr 2026, 23:30 UTC

Ganancias

China Petroleum & Chemical 1Q Rev CNY706.70B Vs. CNY735.36B >0386.HK

28 abr 2026, 23:19 UTC

Charlas de Mercado
Ganancias

Visa Points to Spending Boost from Tax Refunds in U.S. -- Market Talk

28 abr 2026, 23:09 UTC

Ganancias

Visa 2Q Revenue Climbs as Consumers Keep Spending; Board Authorizes $20B Buyback -- Update

28 abr 2026, 23:03 UTC

Charlas de Mercado

Australia's Inflation Outlook Looks Pretty Grim -- Market Talk

28 abr 2026, 23:01 UTC

Noticias de Eventos Importantes

NIESR Sees One Rate Rise to 4% in Benign Scenario

28 abr 2026, 23:01 UTC

Noticias de Eventos Importantes

NIESR Sees U.K. Economy Growing by Just 0.5% in 'Adverse' Middle East Scenario

28 abr 2026, 23:01 UTC

Noticias de Eventos Importantes

NIESR: BOE's Key Rate Should Rise to 5.25% in Adverse Scenario

28 abr 2026, 23:01 UTC

Noticias de Eventos Importantes

U.K.'s NIESR Lowers 2026 U.K. Economic Growth Forecast to 0.9% From 1.4% in 'Benign' Scenario

28 abr 2026, 23:01 UTC

Noticias de Eventos Importantes

NIESR Sees Inflation Peaking at Over 6% in Adverse Scenario

28 abr 2026, 22:51 UTC

Ganancias

Robinhood Earnings Fall Short. A Crypto Slump Is the Culprit. -- Barrons.com

28 abr 2026, 22:48 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

28 abr 2026, 22:48 UTC

Charlas de Mercado

Australia's 1Q CPI Will Likely Provide Little Relief For RBA -- Market Talk

28 abr 2026, 22:40 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Australian 1Q CPI Will Likely Keep May Hike Alive -- Market Talk

28 abr 2026, 22:32 UTC

Ganancias

Booking Beats on Profit. Travel Demand Outlook Clouded By Iran War. -- Barrons.com

28 abr 2026, 22:25 UTC

Adquisiciones, fusiones, absorciones

Pernod Ricard and Brown-Forman End Deal Talks -- Update

28 abr 2026, 22:22 UTC

Ganancias

Prudential PLC 1Q New Business Profit $686.0M, Up 10% on Year

28 abr 2026, 22:17 UTC

Charlas de Mercado

Canada Fiscal Update Puts Central Bank on Track to Raise Rates -- Market Talk

28 abr 2026, 22:14 UTC

Ganancias

Prudential PLC 1Q APE Sales Up 6% on Year, to $1.823B >2378.HK

28 abr 2026, 22:14 UTC

Ganancias

Prudential PLC 1Q New Business Profit $686.0M, Up 10% on Year >2378.HK

28 abr 2026, 22:07 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Canada Chamber Frets Over Lost Fiscal Room -- Market Talk

Comparación entre iguales

Cambio de precio

Cytek Biosciences Inc previsión

Precio Objetivo

By TipRanks

40.13% repunte

Estimación a 12 Meses

Media 6.25 USD  40.13%

Máximo 7.5 USD

Mínimo 5 USD

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Cytek Biosciences Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

2 ratings

1

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

3.7 / 3.8Soporte y Resistencia

Corto Plazo

Weak Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

177 / 348 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Cytek Biosciences Inc

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
help-icon Live chat